Adenosine Triphosphate: Clinical Trials

5 trials of Adenosine Triphosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 withdrawn. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Unknown 2, Withdrawn 1

Follow Adenosine Triphosphate: new trials by email Literature Review of Adenosine Triphosphate trials Research Report on Adenosine Triphosphate

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid Improvement of Depression of Fluoxetine Combined With ATP
Control group: Fluoxetine and Placebo, Experimental group: Fluoxetine and ATP, Control group: Fluoxetine and Phosphocreatine - Depression
Phase 2UnknownNanfang Hospital, Southern Medical University1952020-01-072023-11-15
Rapid Antidepressant Effects of ATP and Phosphocreatine
Placebo, ATP, Phosphocreatine - Major Depressive Disorder
Phase 2UnknownZhujiang Hospital422017-05-032017-05-08
ATP in Alzheimer Disease
ADENOSINE TRIPHOSPHATE, PLACEBO - Alzheimer's Disease
Phase 2CompletedSara Varea202014-12-012017-03-29
Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Retinoic acid, Standard of care - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 2WithdrawnUniversity of North Carolina, Chapel Hill2012-01-012017-02-23
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
abatacept, cyclophosphamide, azathioprine - Lupus Nephritis, Lupus Erythematosus, Systemic
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1372008-11-012016-02-08

Conditions studied

Alzheimer Disease (1)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Glomerulonephritis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)  ·  Vasculitis (1)

Sponsors

Nanfang Hospital, Southern Medical University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Sara Varea (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Zhujiang Hospital (1)

Countries

China (2)  ·  United States (2)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Betty Diamond, MD (1)  ·  Bin Zhang, MD & PhD (1)  ·  David Wofsy, MD (1)  ·  Patrick H Nachman, MD (1)

Results publications

PMID 25403681, PMID 25779381, PMID 30626424

NIH funding

P01DK058335 (1)